|
|
|
|
21 Nov 2008 03:14:07 UTC
Neuralgia pain: NeurogesX Reports Third Quarter 2008 Results SYS-CON Media, NJ - 17 hours ago In October 2008 , the new drug application (NDA) for NGX-4010 for the management of pain associated with postherpetic neuralgia (PHN) was submitted on
|
|
20 Nov 2008 15:30:14 UTC
Neuralgia pain: Astellas Halts Phase II of XenoPort Pain Drug BioWorld Online, GA - 13 hours ago GSK is developing XP13512 under the name Solzira as a treatment for PDN and other pain indications, including postherpetic neuralgia and restless legs
|
|
19 Nov 2008 07:42:01 UTC
Neuralgia pain: Pfizer to Present Data on New Approaches to Pain and Inflammation WELT ONLINE, Germany - Oct 25 neuralgia pain, 2008 LYRICA is indicated for the management of Fibromyalgia neuralgia pain, neuropathic pain associated with Diabetic Peripheral Neuropathy neuralgia pain, Postherpetic Neuralgia neuralgia pain,
|
18 Nov 2008 12:00:46 UTC
Neuralgia pain: EpiCept Corporation Reports Third Quarter 2008 Operating and WELT ONLINE, Germany - 9 hours ago We have also continued our studies with NP-1 neuralgia pain, our neuropathic pain compound neuralgia pain, which we expect to report top-line results by the first quarter of 2009 and the
|
17 Nov 2008 00:20:23 UTC
Neuralgia pain: EpiCept Corporation Reports Third Quarter 2008 Operating and neuralgia pain WELT ONLINE, Germany - 9 hours ago We have also continued neuralgia pain our studies with NP-1, our neuropathic pain compound, neuralgia pain which we expect to report top-line results by the first neuralgia pain quarter of 2009 and the
|
|
|
|
|